CardioComm Solutions, Inc.

EKGGFOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$908878

P/E Ratio—

52W High$0.011

52W Low$0.003

Avg Volume7K

Open$0.01

Beta1.00

Free Cash Flow Financials Revenue

CardioComm Solutions, Inc. (EKGGF) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

EKGGF · free cash flow · updated Jun 15, 2026

Core FCF metrics

EKGGF · FCF · TTM · margin & CAGR

Free cash flow was −$455,217 for FY2025 (fiscal year ending 2025-12-31), down 293.6% year-over-year The FCF margin was -167.4%.

FY2025 Free Cash Flow−$455,217▼ -293.6% YoY

Trailing 12M (TTM)−$455,545trailing 4 quarters sum

FCF Margin-167.4%−$455,217 ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 15, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

EKGGF · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest−$452,712(0M)−$455,217▼ 293.6%-167.4%

FY2024−$110,660(0M)−$115,664▼ 106.2%-22.0%

FY2023−$54,067(0M)−$56,091▼ 226.5%-6.4%

FY2022$54,516(0M)$44,328▲ +135.9%4.5%

FY2021−$120,798(0M)−$123,429▼ 627.4%-18.1%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

EKGGF · P/FCF · FCF yield · FCF per share

CardioComm Solutions, Inc. (EKGGF) reported negative free cash flow of −$0.00B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

EKGGF · cash flow statement · operating / investing / financing

For FY2025, CardioComm Solutions, Inc. generated −$0.5M in operating cash flow and spent 0M in capital expenditures, yielding −$0.5M in free cash flow.

Operating Activities

−$0.5M

Cash from core business operations

2025-12-31

Investing Activities

−$0.0M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$0.4M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF (−$0.5M) − |CapEx| (0M) = FCF (−$0.5M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

EKGGF vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

CardioComm Solutions, Inc.YOU

EKGGF

−$455,217-293.6%-167.4%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

CardioComm Solutions, Inc. (EKGGF) reported free cash flow of −$455,217 for FY2025 (fiscal year ending 2025-12-31), down 293.6% year-over-year. The FCF margin was -167.4%.

Based on available data, CardioComm Solutions, Inc. has maintained positive free cash flow for at least 2 fiscal year(s). FCF peaked at $44,328 in FY2022.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

EKGGF free cash flow · 8 questions

CardioComm Solutions, Inc. free cash flow was −$455,217 for FY2025, down 293.6% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$455,545.

EKGGF free cash flowEKGGF FCFEKGGF FCF 2025EKGGF free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · CardioComm Solutions, Inc. · CardioComm Solutions, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026